Business Context and Reporting Period
This Form 6-K filing by Prana Biotechnology Limited (not Alteryx Therapeutics Ltd) covers the month of October 2012. The document reports a change in the substantial holding interests of Baywick Pty Ltd and its associates, filed pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is a regulatory notice regarding share ownership changes rather than a financial performance report.
Material Changes Versus Prior Period
Baywick Pty Ltd and its associates increased their total voting power in Prana Biotechnology Limited from 6.20% (17,055,000 votes) to 5.23% (17,811,000 votes) as of October 8, 2012. The decrease in percentage voting power despite an increase in absolute share count indicates dilution due to the issuance of new shares by the company.
- January 4, 2012: Sadarajak Pty Ltd purchased 600,000 ordinary shares on-market for $104,564.
- May 1, 2012: Sadarajak Pty Ltd purchased 156,000 ordinary shares on-market for $25,131.
- Dilution: The filing notes a dilution of shareholding due to the issue of new Prana Biotechnology (PBT) shares, with no consideration given for this specific event.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. The document strictly details the mechanics of the substantial holder notice under the Corporations Act 2001.
Investor Verification Checklist
- Verify the total number of issued shares in Prana Biotechnology Limited to confirm the dilution impact on Baywick Pty Ltd's voting percentage.
- Confirm the identity and relationship of associates (NRB Developments, Sadarajak Pty Ltd, Crystal Triangle, G. Kempler) to ensure full aggregation of interests.
- Review the company's capital raising activities between July 2011 and October 2012 to understand the source of the new share issuance causing dilution.
- Check subsequent filings to determine if Baywick Pty Ltd's voting interest has stabilized or continued to change.